Outsourcing in Clinical Trials DACH 2021
In light on the ongoing COVID-19 situation in Switzerland and across Europe, we have taken the decision to postpone OCT DACH until 26th & 27th April 2021.
After an incredibly successful 2nd edition, Outsourcing in Clinical Trials DACH will be taking place in Zurich for 2020.
The 3rd annual edition will focus upon the operational challenges in clinical development found within Germany, Austria and Switzerland. Over 2 days, delegates will discuss the common challenges and trends impacting the region, including steps for defining contractual relationships and getting the maximum from external providers, incentivising good relationships with CROs and constructing defined deadlines.
- Focused conference for the DACH pharma market– Unlike other conferences, our event specifically focuses on the local pharma industry in Switzerland, Germany and Austria, highlighting the current challenges and exciting innovations and opportunities within the market
- Excellent speaker line up – Senior level speakers from leading organisations such as Roche, Janssen and Celgene along with exciting biotechs like Medac and Medigene
- Great and Diverse Sessions – Our OCT DACH covers a variety of topics ranging from COVID-19 updates to Direct to Patient and Data management innovation to CRO relationship
- Unbeatable Networking Opportunities – Meet and network with over 150 senior industry decision makers during our dedicated networking breaks, round tables and interactive sessions
Registration is now open – book your 2020 ticket today!
WHAT TO EXPECT FOR 2020
Join pharma and biotech experts to discuss new trends and opportunities and learn how they optimize their clinical operations enabling you to stay ahead of the game.
Find the right solution providers to partner with, allowing you to accelerate your trial timelines.
WHY THIS IS YOUR UNMISSABLE CONFERENCE
This is an exceptional networking opportunity for industry accelerators. Meet industry C-Suite and Director level executives and make valuable connection at this annual thought leadership platform.
Join like-minded peers to learn new perspectives and case studies through presentation, panel discussions, interactive round tables and workshops.
The conference discusses the vital connections between process, tools and techniques to manage change. Update your knowledge to create new strategies enabling you to enact change.
Linical is a global speciality CRO headquartered in Osaka, Japan, listed in the prime segment of the Tokyo Stock exchange, and dedicated to serve its clients as a true partner in development. With more than 900 employees Linical directly covers more than 20 countries and all key markets in Asia-Pacific, Japan, Europe and N. America via its own offices.
Metronomia is a German clinical research organization (CRO) committed to high quality, best service and outstanding flexibility. A service oriented, stable and highly skilled team provides e-clinical services,clinicaldata management and biostatistical services within phase I – IV and non-interventional studies in allmajor therapeutic areas.
Pharm-Olam International delivers cost effective, quality clinical services to pharma and biotech sponsors across all therapeutic areas in more than 40 countries. Since 1994, we have been committed to our objective: to create value for our clients by satisfying their clinical development needs with consistent and dependable solutions and services.